SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2zec'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1AQ7_B_AG2B4_1 (TRYPSIN AERUGINOSIN 98-B)	2zec	TRYPTASE BETA 2 (Homo sapiens)	7 / 8	HIS A 59 ASP A 203 SER A 204 SER A 209 VAL A 227 GLY A 230 GLY A 240	None 11N A 1 (-2.6A) 11N A 1 (-3.5A) 11N A 1 (-3.3A) None 11N A 1 (-3.9A) 11N A 1 (-3.6A)	0.50A	1aq7A-2zecA: 32.4	1aq7A-2zecA: 40.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BCU_H_PRLH280_0 (ALPHA-THROMBIN)	2zec	TRYPTASE BETA 2 (Homo sapiens)	6 / 9	ASP A 203 SER A 209 VAL A 227 TRP A 229 GLY A 230 GLY A 240	11N A 1 (-2.6A) 11N A 1 (-3.3A) None None 11N A 1 (-3.9A) 11N A 1 (-3.6A)	0.52A	1bcuH-2zecA: 33.7	1bcuH-2zecA: 35.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1DWC_H_MITH1_1 (ALPHA-THROMBIN (LARGE SUBUNIT))	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 9	HIS A 59 ASP A 203 SER A 209 TRP A 229 GLY A 240	None 11N A 1 (-2.6A) 11N A 1 (-3.3A) None 11N A 1 (-3.6A)	0.43A	1dwcH-2zecA: 33.2	1dwcH-2zecA: 35.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ETR_H_MITH1_1 (EPSILON-THROMBIN)	2zec	TRYPTASE BETA 2 (Homo sapiens)	7 / 12	HIS A 59 ASP A 203 SER A 209 VAL A 227 TRP A 229 GLY A 230 GLY A 240	None 11N A 1 (-2.6A) 11N A 1 (-3.3A) None None 11N A 1 (-3.9A) 11N A 1 (-3.6A)	0.55A	1etrH-2zecA: 33.3	1etrH-2zecA: 36.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1F5L_A_AMRA301_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	2zec	TRYPTASE BETA 2 (Homo sapiens)	7 / 8	ASP A 203 SER A 204 GLN A 206 SER A 209 VAL A 227 GLY A 230 GLY A 240	11N A 1 (-2.6A) 11N A 1 (-3.5A) None 11N A 1 (-3.3A) None 11N A 1 (-3.9A) 11N A 1 (-3.6A)	0.43A	1f5lA-2zecA: 34.0	1f5lA-2zecA: 35.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RQP_B_SAMB500_1 (5'-FLUORO-5'-DEOXYAD ENOSINE SYNTHASE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	4 / 8	ASP A 106 PHE A 98 SER A 209 ALA A 108	None None 11N A 1 (-3.3A) None	1.05A	1rqpC-2zecA: undetectable	1rqpC-2zecA: 21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RQP_C_SAMC500_0 (5'-FLUORO-5'-DEOXYAD ENOSINE SYNTHASE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	4 / 8	ASP A 106 PHE A 98 SER A 209 ALA A 108	None None 11N A 1 (-3.3A) None	1.04A	1rqpA-2zecA: undetectable	1rqpA-2zecA: 21.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TNL_A_TPAA900_1 (TRYPSIN)	2zec	TRYPTASE BETA 2 (Homo sapiens)	6 / 6	ASP A 203 SER A 204 SER A 209 VAL A 227 GLY A 230 GLY A 240	11N A 1 (-2.6A) 11N A 1 (-3.5A) 11N A 1 (-3.3A) None 11N A 1 (-3.9A) 11N A 1 (-3.6A)	0.36A	1tnlA-2zecA: 32.7	1tnlA-2zecA: 40.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Y4L_B_SVRB301_1 (PHOSPHOLIPASE A2 HOMOLOG 2)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	GLY A 45 GLY A 211 LEU A 213 GLY A 225 LYS A 26	None	1.19A	1y4lA-2zecA: undetectable	1y4lA-2zecA: 15.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OA1_B_ADNB2005_1 (TRYPTOPHAN HALOGENASE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	4 / 7	GLY A 46 GLY A 211 VAL A 73 LEU A 110	None	0.76A	2oa1B-2zecA: undetectable	2oa1B-2zecA: 18.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OTV_A_NCAA1301_0 (CATIONIC TRYPSIN)	2zec	TRYPTASE BETA 2 (Homo sapiens)	6 / 6	ASP A 203 SER A 204 SER A 209 VAL A 227 GLY A 230 GLY A 240	11N A 1 (-2.6A) 11N A 1 (-3.5A) 11N A 1 (-3.3A) None 11N A 1 (-3.9A) 11N A 1 (-3.6A)	0.36A	2otvA-2zecA: 32.9	2otvA-2zecA: 40.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2P16_A_GG2A298_1 (COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR))	2zec	TRYPTASE BETA 2 (Homo sapiens)	7 / 12	ASP A 203 SER A 209 VAL A 227 TRP A 229 GLY A 230 GLY A 240 TYR A 242	11N A 1 (-2.6A) 11N A 1 (-3.3A) None None 11N A 1 (-3.9A) 11N A 1 (-3.6A) None	0.38A	2p16A-2zecA: 32.9	2p16A-2zecA: 34.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VIN_A_505A1247_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B)	2zec	TRYPTASE BETA 2 (Homo sapiens)	7 / 8	ASP A 203 SER A 204 GLN A 206 SER A 209 VAL A 227 GLY A 230 GLY A 240	11N A 1 (-2.6A) 11N A 1 (-3.5A) None 11N A 1 (-3.3A) None 11N A 1 (-3.9A) 11N A 1 (-3.6A)	0.36A	2vinA-2zecA: 34.4	2vinA-2zecA: 35.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W26_A_RIVA1001_1 (ACTIVATED FACTOR XA HEAVY CHAIN)	2zec	TRYPTASE BETA 2 (Homo sapiens)	8 / 12	ASP A 203 SER A 209 VAL A 227 TRP A 229 GLY A 230 GLY A 232 GLY A 240 TYR A 242	11N A 1 (-2.6A) 11N A 1 (-3.3A) None None 11N A 1 (-3.9A) 11N A 1 (-3.8A) 11N A 1 (-3.6A) None	0.47A	2w26A-2zecA: 32.9	2w26A-2zecA: 34.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BOG_C_DVAC59_0 (6.5 KDA GLYCINE-RICH ANTIFREEZE PROTEIN)	2zec	TRYPTASE BETA 2 (Homo sapiens)	3 / 3	GLY A 211 GLY A 207 GLY A 45	None	0.41A	3bogC-2zecA: undetectable	3bogC-2zecA: 15.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GY3_A_PNTA246_0 (CATIONIC TRYPSIN)	2zec	TRYPTASE BETA 2 (Homo sapiens)	7 / 11	HIS A 59 ASP A 203 SER A 204 SER A 209 TRP A 229 GLY A 230 GLY A 240	None 11N A 1 (-2.6A) 11N A 1 (-3.5A) 11N A 1 (-3.3A) None 11N A 1 (-3.9A) 11N A 1 (-3.6A)	0.33A	3gy3A-2zecA: 12.7	3gy3A-2zecA: 40.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3I5U_B_SAMB401_0 (O-METHYLTRANSFERASE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	LEU A 110 GLY A 45 GLY A 46 SER A 204 ASP A 106	None None None 11N A 1 (-3.5A) None	1.09A	3i5uB-2zecA: undetectable	3i5uB-2zecA: 20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OU6_C_SAMC300_0 (SAM-DEPENDENT METHYLTRANSFERASE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	LEU A 33 ALA A 57 TRP A 229 GLY A 46 ALA A 101	None	1.21A	3ou6C-2zecA: undetectable	3ou6C-2zecA: 20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OU7_C_SAMC300_0 (SAM-DEPENDENT METHYLTRANSFERASE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	LEU A 33 ALA A 57 TRP A 229 GLY A 46 ALA A 101	None	1.24A	3ou7C-2zecA: undetectable	3ou7C-2zecA: 20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PGH_C_FLPC701_1 (CYCLOOXYGENASE-2)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	VAL A 61 VAL A 54 VAL A 226 GLY A 211 LEU A 33	None	0.92A	3pghC-2zecA: undetectable	3pghC-2zecA: 16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RR3_A_FLRA700_1 (PROSTAGLANDIN G/H SYNTHASE 2)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	VAL A 61 VAL A 54 VAL A 226 GLY A 211 LEU A 33	None	0.83A	3rr3A-2zecA: undetectable	3rr3A-2zecA: 16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RR3_B_FLRB700_1 (PROSTAGLANDIN G/H SYNTHASE 2)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	VAL A 61 VAL A 54 VAL A 226 GLY A 211 LEU A 33	None	0.83A	3rr3B-2zecA: undetectable	3rr3B-2zecA: 16.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	2zec	TRYPTASE BETA 2 (Homo sapiens)	6 / 6	SER A 204 SER A 209 VAL A 227 TRP A 229 GLY A 230 GLY A 240	11N A 1 (-3.5A) 11N A 1 (-3.3A) None None 11N A 1 (-3.9A) 11N A 1 (-3.6A)	0.41A	3rxfA-2zecA: 13.5	3rxfA-2zecA: 40.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXH_A_HSMA7_1 (CATIONIC TRYPSIN)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 5	ASP A 203 SER A 204 SER A 209 VAL A 227 GLY A 240	11N A 1 (-2.6A) 11N A 1 (-3.5A) 11N A 1 (-3.3A) None 11N A 1 (-3.6A)	0.35A	3rxhA-2zecA: 32.8	3rxhA-2zecA: 40.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VAQ_A_ADNA401_1 (PUTATIVE ADENOSINE KINASE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	LEU A 71 GLY A 211 GLY A 210 LEU A 110 GLY A 146	None	1.04A	3vaqA-2zecA: undetectable	3vaqA-2zecA: 19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VAS_A_ADNA401_1 (PUTATIVE ADENOSINE KINASE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	LEU A 71 GLY A 211 GLY A 210 LEU A 110 GLY A 146	None	1.06A	3vasA-2zecA: undetectable	3vasA-2zecA: 19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VAS_B_ADNB401_1 (PUTATIVE ADENOSINE KINASE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	LEU A 71 GLY A 211 GLY A 210 LEU A 110 GLY A 146	None	1.05A	3vasB-2zecA: undetectable	3vasB-2zecA: 19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BBO_B_ACTB1114_0 (BLR5658 PROTEIN)	2zec	TRYPTASE BETA 2 (Homo sapiens)	3 / 3	TRP A 141 TRP A 27 THR A 143	None	1.49A	4bboB-2zecA: undetectable	4bboB-2zecA: 17.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4FU8_A_ACTA302_0 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	2zec	TRYPTASE BETA 2 (Homo sapiens)	4 / 5	HIS A 59 GLN A 206 GLY A 207 SER A 209	None None None 11N A 1 (-3.3A)	0.32A	4fu8A-2zecA: 34.2	4fu8A-2zecA: 35.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HFP_D_15UD402_1 (PROTHROMBIN)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	HIS A 59 ASP A 203 VAL A 227 TRP A 229 GLY A 240	None 11N A 1 (-2.6A) None None 11N A 1 (-3.6A)	0.37A	4hfpD-2zecA: 33.1	4hfpD-2zecA: 35.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QDJ_A_SAMA301_0 (MAGNESIUM-PROTOPORPH YRIN O-METHYLTRANSFERASE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	VAL A 245 GLY A 46 ILE A 107 LEU A 109 LEU A 48	None	1.03A	4qdjA-2zecA: undetectable	4qdjA-2zecA: 19.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RN6_B_15UB301_1 (THROMBIN HEAVY CHAIN)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	HIS A 59 VAL A 227 TRP A 229 GLY A 230 GLY A 240	None None None 11N A 1 (-3.9A) 11N A 1 (-3.6A)	0.48A	4rn6B-2zecA: 28.0	4rn6B-2zecA: 35.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4W5O_A_IPHA906_0 (PROTEIN ARGONAUTE-2)	2zec	TRYPTASE BETA 2 (Homo sapiens)	4 / 5	PHE A 98 PRO A 96 VAL A 94 ALA A 105	None	0.89A	4w5oA-2zecA: undetectable	4w5oA-2zecA: 15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4C_A_IPHA905_0 (PROTEIN ARGONAUTE-2)	2zec	TRYPTASE BETA 2 (Homo sapiens)	4 / 5	PHE A 98 PRO A 96 VAL A 94 ALA A 105	None	0.90A	4z4cA-2zecA: undetectable	4z4cA-2zecA: 15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4D_A_IPHA904_0 (PROTEIN ARGONAUTE-2)	2zec	TRYPTASE BETA 2 (Homo sapiens)	4 / 5	PHE A 98 PRO A 96 VAL A 94 ALA A 105	None	0.91A	4z4dA-2zecA: undetectable	4z4dA-2zecA: 15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4E_A_IPHA906_0 (PROTEIN ARGONAUTE-2)	2zec	TRYPTASE BETA 2 (Homo sapiens)	4 / 5	PHE A 98 PRO A 96 VAL A 94 ALA A 105	None	0.90A	4z4eA-2zecA: undetectable	4z4eA-2zecA: 15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AXD_A_RBVA502_2 (ADENOSYLHOMOCYSTEINA SE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	3 / 3	THR A 124 HIS A 254 LEU A 109	None	0.79A	5axdA-2zecA: undetectable	5axdA-2zecA: 19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AXD_C_RBVC502_2 (ADENOSYLHOMOCYSTEINA SE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	3 / 3	THR A 124 HIS A 254 LEU A 109	None	0.80A	5axdC-2zecA: undetectable	5axdC-2zecA: 19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EIW_C_SAMC4000_0 (NS5 METHYLTRANSFERASE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	6 / 12	GLY A 146 GLY A 46 GLY A 210 GLY A 207 THR A 56 VAL A 54	None	1.26A	5eiwC-2zecA: undetectable	5eiwC-2zecA: 21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IKT_A_TLFA601_0 (PROSTAGLANDIN G/H SYNTHASE 2)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	VAL A 61 VAL A 54 VAL A 226 GLY A 211 LEU A 33	None	0.90A	5iktA-2zecA: undetectable	5iktA-2zecA: 16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5T7B_A_IPHA901_0 (PROTEIN ARGONAUTE-2)	2zec	TRYPTASE BETA 2 (Homo sapiens)	4 / 6	PHE A 98 PRO A 96 VAL A 94 ALA A 105	None	0.91A	5t7bA-2zecA: undetectable	5t7bA-2zecA: 14.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VIM_A_SAMA301_0 (METHYLTRANSFERASE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	GLY A 146 GLY A 210 GLY A 45 GLY A 144 PHE A 98	None	0.92A	5vimA-2zecA: undetectable	5vimA-2zecA: 19.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VIM_B_SAMB301_0 (METHYLTRANSFERASE)	2zec	TRYPTASE BETA 2 (Homo sapiens)	5 / 12	GLY A 146 GLY A 210 GLY A 45 GLY A 144 PHE A 98	None	0.93A	5vimB-2zecA: undetectable	5vimB-2zecA: 19.06

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AQ7_B_AG2B4_1","TRYPSIN;AERUGINOSIN 98-B","2zec","TRYPTASE BETA 2","Homo sapiens",7,"HIS A  59;ASP A 203;SER A 204;SER A 209;VAL A 227;GLY A 230;GLY A 240","None;11N A   1 (-2.6A);11N A   1 (-3.5A);11N A   1 (-3.3A);None;11N A   1 (-3.9A);11N A   1 (-3.6A)","0.50A","1aq7A-2zecA:32.4","1aq7A-2zecA:40.16"],["1BCU_H_PRLH280_0","ALPHA-THROMBIN","2zec","TRYPTASE BETA 2","Homo sapiens",6,"ASP A 203;SER A 209;VAL A 227;TRP A 229;GLY A 230;GLY A 240","11N A   1 (-2.6A);11N A   1 (-3.3A);None;None;11N A   1 (-3.9A);11N A   1 (-3.6A)","0.52A","1bcuH-2zecA:33.7","1bcuH-2zecA:35.69"],["1DWC_H_MITH1_1","ALPHA-THROMBIN (LARGE SUBUNIT)","2zec","TRYPTASE BETA 2","Homo sapiens",5,"HIS A  59;ASP A 203;SER A 209;TRP A 229;GLY A 240","None;11N A   1 (-2.6A);11N A   1 (-3.3A);None;11N A   1 (-3.6A)","0.43A","1dwcH-2zecA:33.2","1dwcH-2zecA:35.69"],["1ETR_H_MITH1_1","EPSILON-THROMBIN","2zec","TRYPTASE BETA 2","Homo sapiens",7,"HIS A  59;ASP A 203;SER A 209;VAL A 227;TRP A 229;GLY A 230;GLY A 240","None;11N A   1 (-2.6A);11N A   1 (-3.3A);None;None;11N A   1 (-3.9A);11N A   1 (-3.6A)","0.55A","1etrH-2zecA:33.3","1etrH-2zecA:36.57"],["1F5L_A_AMRA301_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","2zec","TRYPTASE BETA 2","Homo sapiens",7,"ASP A 203;SER A 204;GLN A 206;SER A 209;VAL A 227;GLY A 230;GLY A 240","11N A   1 (-2.6A);11N A   1 (-3.5A);None;11N A   1 (-3.3A);None;11N A   1 (-3.9A);11N A   1 (-3.6A)","0.43A","1f5lA-2zecA:34.0","1f5lA-2zecA:35.66"],["1RQP_B_SAMB500_1","5'-FLUORO-5'-DEOXYADENOSINE SYNTHASE","2zec","TRYPTASE BETA 2","Homo sapiens",4,"ASP A 106;PHE A  98;SER A 209;ALA A 108","None;None;11N A   1 (-3.3A);None","1.05A","1rqpC-2zecA:undetectable","1rqpC-2zecA:21.05"],["1RQP_C_SAMC500_0","5'-FLUORO-5'-DEOXYADENOSINE SYNTHASE","2zec","TRYPTASE BETA 2","Homo sapiens",4,"ASP A 106;PHE A  98;SER A 209;ALA A 108","None;None;11N A   1 (-3.3A);None","1.04A","1rqpA-2zecA:undetectable","1rqpA-2zecA:21.05"],["1TNL_A_TPAA900_1","TRYPSIN","2zec","TRYPTASE BETA 2","Homo sapiens",6,"ASP A 203;SER A 204;SER A 209;VAL A 227;GLY A 230;GLY A 240","11N A   1 (-2.6A);11N A   1 (-3.5A);11N A   1 (-3.3A);None;11N A   1 (-3.9A);11N A   1 (-3.6A)","0.36A","1tnlA-2zecA:32.7","1tnlA-2zecA:40.16"],["1Y4L_B_SVRB301_1","PHOSPHOLIPASE A2 HOMOLOG 2;PHOSPHOLIPASE A2 HOMOLOG 2","2zec","TRYPTASE BETA 2","Homo sapiens",5,"GLY A  45;GLY A 211;LEU A 213;GLY A 225;LYS A  26","None","1.19A","1y4lA-2zecA:undetectable","1y4lA-2zecA:15.35"],["2OA1_B_ADNB2005_1","TRYPTOPHAN HALOGENASE","2zec","TRYPTASE BETA 2","Homo sapiens",4,"GLY A  46;GLY A 211;VAL A  73;LEU A 110","None","0.76A","2oa1B-2zecA:undetectable","2oa1B-2zecA:18.98"],["2OTV_A_NCAA1301_0","CATIONIC TRYPSIN","2zec","TRYPTASE BETA 2","Homo sapiens",6,"ASP A 203;SER A 204;SER A 209;VAL A 227;GLY A 230;GLY A 240","11N A   1 (-2.6A);11N A   1 (-3.5A);11N A   1 (-3.3A);None;11N A   1 (-3.9A);11N A   1 (-3.6A)","0.36A","2otvA-2zecA:32.9","2otvA-2zecA:40.16"],["2P16_A_GG2A298_1","COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR)","2zec","TRYPTASE BETA 2","Homo sapiens",7,"ASP A 203;SER A 209;VAL A 227;TRP A 229;GLY A 230;GLY A 240;TYR A 242","11N A   1 (-2.6A);11N A   1 (-3.3A);None;None;11N A   1 (-3.9A);11N A   1 (-3.6A);None","0.38A","2p16A-2zecA:32.9","2p16A-2zecA:34.80"],["2VIN_A_505A1247_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B","2zec","TRYPTASE BETA 2","Homo sapiens",7,"ASP A 203;SER A 204;GLN A 206;SER A 209;VAL A 227;GLY A 230;GLY A 240","11N A   1 (-2.6A);11N A   1 (-3.5A);None;11N A   1 (-3.3A);None;11N A   1 (-3.9A);11N A   1 (-3.6A)","0.36A","2vinA-2zecA:34.4","2vinA-2zecA:35.66"],["2W26_A_RIVA1001_1","ACTIVATED FACTOR XA HEAVY CHAIN","2zec","TRYPTASE BETA 2","Homo sapiens",8,"ASP A 203;SER A 209;VAL A 227;TRP A 229;GLY A 230;GLY A 232;GLY A 240;TYR A 242","11N A   1 (-2.6A);11N A   1 (-3.3A);None;None;11N A   1 (-3.9A);11N A   1 (-3.8A);11N A   1 (-3.6A);None","0.47A","2w26A-2zecA:32.9","2w26A-2zecA:34.80"],["3BOG_C_DVAC59_0","6.5 KDA GLYCINE-RICH ANTIFREEZE PROTEIN","2zec","TRYPTASE BETA 2","Homo sapiens",3,"GLY A 211;GLY A 207;GLY A  45","None","0.41A","3bogC-2zecA:undetectable","3bogC-2zecA:15.29"],["3GY3_A_PNTA246_0","CATIONIC TRYPSIN","2zec","TRYPTASE BETA 2","Homo sapiens",7,"HIS A  59;ASP A 203;SER A 204;SER A 209;TRP A 229;GLY A 230;GLY A 240","None;11N A   1 (-2.6A);11N A   1 (-3.5A);11N A   1 (-3.3A);None;11N A   1 (-3.9A);11N A   1 (-3.6A)","0.33A","3gy3A-2zecA:12.7","3gy3A-2zecA:40.16"],["3I5U_B_SAMB401_0","O-METHYLTRANSFERASE","2zec","TRYPTASE BETA 2","Homo sapiens",5,"LEU A 110;GLY A  45;GLY A  46;SER A 204;ASP A 106","None;None;None;11N A   1 (-3.5A);None","1.09A","3i5uB-2zecA:undetectable","3i5uB-2zecA:20.88"],["3OU6_C_SAMC300_0","SAM-DEPENDENT METHYLTRANSFERASE","2zec","TRYPTASE BETA 2","Homo sapiens",5,"LEU A  33;ALA A  57;TRP A 229;GLY A  46;ALA A 101","None","1.21A","3ou6C-2zecA:undetectable","3ou6C-2zecA:20.61"],["3OU7_C_SAMC300_0","SAM-DEPENDENT METHYLTRANSFERASE","2zec","TRYPTASE BETA 2","Homo sapiens",5,"LEU A  33;ALA A  57;TRP A 229;GLY A  46;ALA A 101","None","1.24A","3ou7C-2zecA:undetectable","3ou7C-2zecA:20.61"],["3PGH_C_FLPC701_1","CYCLOOXYGENASE-2","2zec","TRYPTASE BETA 2","Homo sapiens",5,"VAL A  61;VAL A  54;VAL A 226;GLY A 211;LEU A  33","None","0.92A","3pghC-2zecA:undetectable","3pghC-2zecA:16.72"],["3RR3_A_FLRA700_1","PROSTAGLANDIN G\/H SYNTHASE 2","2zec","TRYPTASE BETA 2","Homo sapiens",5,"VAL A  61;VAL A  54;VAL A 226;GLY A 211;LEU A  33","None","0.83A","3rr3A-2zecA:undetectable","3rr3A-2zecA:16.22"],["3RR3_B_FLRB700_1","PROSTAGLANDIN G\/H SYNTHASE 2","2zec","TRYPTASE BETA 2","Homo sapiens",5,"VAL A  61;VAL A  54;VAL A 226;GLY A 211;LEU A  33","None","0.83A","3rr3B-2zecA:undetectable","3rr3B-2zecA:16.22"],["3RXF_A_4APA9_1","CATIONIC TRYPSIN","2zec","TRYPTASE BETA 2","Homo sapiens",6,"SER A 204;SER A 209;VAL A 227;TRP A 229;GLY A 230;GLY A 240","11N A   1 (-3.5A);11N A   1 (-3.3A);None;None;11N A   1 (-3.9A);11N A   1 (-3.6A)","0.41A","3rxfA-2zecA:13.5","3rxfA-2zecA:40.16"],["3RXH_A_HSMA7_1","CATIONIC TRYPSIN","2zec","TRYPTASE BETA 2","Homo sapiens",5,"ASP A 203;SER A 204;SER A 209;VAL A 227;GLY A 240","11N A   1 (-2.6A);11N A   1 (-3.5A);11N A   1 (-3.3A);None;11N A   1 (-3.6A)","0.35A","3rxhA-2zecA:32.8","3rxhA-2zecA:40.16"],["3VAQ_A_ADNA401_1","PUTATIVE ADENOSINE KINASE","2zec","TRYPTASE BETA 2","Homo sapiens",5,"LEU A  71;GLY A 211;GLY A 210;LEU A 110;GLY A 146","None","1.04A","3vaqA-2zecA:undetectable","3vaqA-2zecA:19.26"],["3VAS_A_ADNA401_1","PUTATIVE ADENOSINE KINASE","2zec","TRYPTASE BETA 2","Homo sapiens",5,"LEU A  71;GLY A 211;GLY A 210;LEU A 110;GLY A 146","None","1.06A","3vasA-2zecA:undetectable","3vasA-2zecA:19.58"],["3VAS_B_ADNB401_1","PUTATIVE ADENOSINE KINASE","2zec","TRYPTASE BETA 2","Homo sapiens",5,"LEU A  71;GLY A 211;GLY A 210;LEU A 110;GLY A 146","None","1.05A","3vasB-2zecA:undetectable","3vasB-2zecA:19.58"],["4BBO_B_ACTB1114_0","BLR5658 PROTEIN","2zec","TRYPTASE BETA 2","Homo sapiens",3,"TRP A 141;TRP A  27;THR A 143","None","1.49A","4bboB-2zecA:undetectable","4bboB-2zecA:17.52"],["4FU8_A_ACTA302_0","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","2zec","TRYPTASE BETA 2","Homo sapiens",4,"HIS A  59;GLN A 206;GLY A 207;SER A 209","None;None;None;11N A   1 (-3.3A)","0.32A","4fu8A-2zecA:34.2","4fu8A-2zecA:35.80"],["4HFP_D_15UD402_1","PROTHROMBIN","2zec","TRYPTASE BETA 2","Homo sapiens",5,"HIS A  59;ASP A 203;VAL A 227;TRP A 229;GLY A 240","None;11N A   1 (-2.6A);None;None;11N A   1 (-3.6A)","0.37A","4hfpD-2zecA:33.1","4hfpD-2zecA:35.32"],["4QDJ_A_SAMA301_0","MAGNESIUM-PROTOPORPHYRIN O-METHYLTRANSFERASE","2zec","TRYPTASE BETA 2","Homo sapiens",5,"VAL A 245;GLY A  46;ILE A 107;LEU A 109;LEU A  48","None","1.03A","4qdjA-2zecA:undetectable","4qdjA-2zecA:19.29"],["4RN6_B_15UB301_1","THROMBIN HEAVY CHAIN","2zec","TRYPTASE BETA 2","Homo sapiens",5,"HIS A  59;VAL A 227;TRP A 229;GLY A 230;GLY A 240","None;None;None;11N A   1 (-3.9A);11N A   1 (-3.6A)","0.48A","4rn6B-2zecA:28.0","4rn6B-2zecA:35.32"],["4W5O_A_IPHA906_0","PROTEIN ARGONAUTE-2","2zec","TRYPTASE BETA 2","Homo sapiens",4,"PHE A  98;PRO A  96;VAL A  94;ALA A 105","None","0.89A","4w5oA-2zecA:undetectable","4w5oA-2zecA:15.00"],["4Z4C_A_IPHA905_0","PROTEIN ARGONAUTE-2","2zec","TRYPTASE BETA 2","Homo sapiens",4,"PHE A  98;PRO A  96;VAL A  94;ALA A 105","None","0.90A","4z4cA-2zecA:undetectable","4z4cA-2zecA:15.00"],["4Z4D_A_IPHA904_0","PROTEIN ARGONAUTE-2","2zec","TRYPTASE BETA 2","Homo sapiens",4,"PHE A  98;PRO A  96;VAL A  94;ALA A 105","None","0.91A","4z4dA-2zecA:undetectable","4z4dA-2zecA:15.00"],["4Z4E_A_IPHA906_0","PROTEIN ARGONAUTE-2","2zec","TRYPTASE BETA 2","Homo sapiens",4,"PHE A  98;PRO A  96;VAL A  94;ALA A 105","None","0.90A","4z4eA-2zecA:undetectable","4z4eA-2zecA:15.00"],["5AXD_A_RBVA502_2","ADENOSYLHOMOCYSTEINASE","2zec","TRYPTASE BETA 2","Homo sapiens",3,"THR A 124;HIS A 254;LEU A 109","None","0.79A","5axdA-2zecA:undetectable","5axdA-2zecA:19.12"],["5AXD_C_RBVC502_2","ADENOSYLHOMOCYSTEINASE","2zec","TRYPTASE BETA 2","Homo sapiens",3,"THR A 124;HIS A 254;LEU A 109","None","0.80A","5axdC-2zecA:undetectable","5axdC-2zecA:19.12"],["5EIW_C_SAMC4000_0","NS5 METHYLTRANSFERASE","2zec","TRYPTASE BETA 2","Homo sapiens",6,"GLY A 146;GLY A  46;GLY A 210;GLY A 207;THR A  56;VAL A  54","None","1.26A","5eiwC-2zecA:undetectable","5eiwC-2zecA:21.45"],["5IKT_A_TLFA601_0","PROSTAGLANDIN G\/H SYNTHASE 2","2zec","TRYPTASE BETA 2","Homo sapiens",5,"VAL A  61;VAL A  54;VAL A 226;GLY A 211;LEU A  33","None","0.90A","5iktA-2zecA:undetectable","5iktA-2zecA:16.01"],["5T7B_A_IPHA901_0","PROTEIN ARGONAUTE-2","2zec","TRYPTASE BETA 2","Homo sapiens",4,"PHE A  98;PRO A  96;VAL A  94;ALA A 105","None","0.91A","5t7bA-2zecA:undetectable","5t7bA-2zecA:14.68"],["5VIM_A_SAMA301_0","METHYLTRANSFERASE","2zec","TRYPTASE BETA 2","Homo sapiens",5,"GLY A 146;GLY A 210;GLY A  45;GLY A 144;PHE A  98","None","0.92A","5vimA-2zecA:undetectable","5vimA-2zecA:19.06"],["5VIM_B_SAMB301_0","METHYLTRANSFERASE","2zec","TRYPTASE BETA 2","Homo sapiens",5,"GLY A 146;GLY A 210;GLY A  45;GLY A 144;PHE A  98","None","0.93A","5vimB-2zecA:undetectable","5vimB-2zecA:19.06"]]